Product Information
PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE is a generic product labeled by Prasco Laboratories, priced at $3.3727 per EA under NDC 66993078130. Its NADAC has been published 45 times since Aug 20, 2025.
Strength
7.5; 46 mg/1; mg/1
Manufacturer
Prasco LaboratoriesNDC
66993078130
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENTERMINE HYDROCHLORIDE; TOPIRAMATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022580On Market Since
6/1/2025
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE has been published 45 times since Aug 20, 2025, and over the history we have for it it has declined 27.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.3727 per EA |
|---|---|
| All-time high | $4.6508 (Sep 10, 2025) |
| All-time low | $3.1410 (Feb 18, 2026) |
| 52-week high | $4.6508 |
| 52-week low | $3.1410 |
| Median price | $3.6427 |
| Average price | $3.6215 |
| Largest weekly change | -14.2% (Sep 17, 2025) |
| Weeks tracked | 45 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE, manufactured by Prasco Laboratories, is $3.3727 per EA (NDC 66993078130), effective Jun 24, 2026.
How has the price of PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE has declined 27.5%. It has been tracked across 45 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE?
Since Aug 20, 2025, the NADAC for PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE has ranged from a low of $3.1410 (Feb 18, 2026) to a high of $4.6508 (Sep 10, 2025), with a median of $3.6427 per EA.
Are there cheaper alternatives to PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE, but none are currently priced below it.
Who manufactures PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE?
PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE (NDC 66993078130) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification